397 related articles for article (PubMed ID: 35280755)
1. Clinical Applications and Anticancer Effects of Antimicrobial Peptides: From Bench to Bedside.
Jafari A; Babajani A; Sarrami Forooshani R; Yazdani M; Rezaei-Tavirani M
Front Oncol; 2022; 12():819563. PubMed ID: 35280755
[TBL] [Abstract][Full Text] [Related]
2. Cancer Wars: Revenge of the AMPs (Antimicrobial Peptides), a New Strategy against Colorectal Cancer.
Răileanu M; Bacalum M
Toxins (Basel); 2023 Jul; 15(7):. PubMed ID: 37505728
[TBL] [Abstract][Full Text] [Related]
3. Anticancer activities of natural antimicrobial peptides from animals.
Qu B; Yuan J; Liu X; Zhang S; Ma X; Lu L
Front Microbiol; 2023; 14():1321386. PubMed ID: 38298540
[TBL] [Abstract][Full Text] [Related]
4. Bioactive peptides for anticancer therapies.
Zhang Y; Wang C; Zhang W; Li X
Biomater Transl; 2023; 4(1):5-17. PubMed ID: 37206303
[TBL] [Abstract][Full Text] [Related]
5. From antimicrobial to anticancer peptides. A review.
Gaspar D; Veiga AS; Castanho MA
Front Microbiol; 2013 Oct; 4():294. PubMed ID: 24101917
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial/anticancer peptides: bioactive molecules and therapeutic agents.
Kardani K; Bolhassani A
Immunotherapy; 2021 Jun; 13(8):669-684. PubMed ID: 33878901
[TBL] [Abstract][Full Text] [Related]
7. Peptides with Dual Antimicrobial and Anticancer Activities.
Felício MR; Silva ON; Gonçalves S; Santos NC; Franco OL
Front Chem; 2017; 5():5. PubMed ID: 28271058
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial Peptides: Potential Application in Liver Cancer.
Zhang C; Yang M; Ericsson AC
Front Microbiol; 2019; 10():1257. PubMed ID: 31231341
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial peptides: a promising strategy for lung cancer drug discovery?
Zandsalimi F; Talaei S; Noormohammad Ahari M; Aghamiri S; Raee P; Roshanzamiri S; Yarian F; Bandehpour M; Zohrab Zadeh Z
Expert Opin Drug Discov; 2020 Nov; 15(11):1343-1354. PubMed ID: 32749935
[TBL] [Abstract][Full Text] [Related]
10. Chemical Strategies towards the Development of Effective Anticancer Peptides.
Li C; Jin K
Curr Med Chem; 2024; 31(14):1839-1873. PubMed ID: 37170992
[TBL] [Abstract][Full Text] [Related]
11. CancerGram: An Effective Classifier for Differentiating Anticancer from Antimicrobial Peptides.
Burdukiewicz M; Sidorczuk K; Rafacz D; Pietluch F; Bąkała M; Słowik J; Gagat P
Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33142753
[TBL] [Abstract][Full Text] [Related]
12. Exploratory data analysis of physicochemical parameters of natural antimicrobial and anticancer peptides: Unraveling the patterns and trends for the rational design of novel peptides.
Saini S; Rathore A; Sharma S; Saini A
Bioimpacts; 2024; 14(1):26438. PubMed ID: 38327633
[TBL] [Abstract][Full Text] [Related]
13. Mode of action of anticancer peptides (ACPs) from amphibian origin.
Oelkrug C; Hartke M; Schubert A
Anticancer Res; 2015 Feb; 35(2):635-43. PubMed ID: 25667440
[TBL] [Abstract][Full Text] [Related]
14. Protocols for Studying Antimicrobial Peptides (AMPs) as Anticancer Agents.
Madera L; Hoskin DW
Methods Mol Biol; 2017; 1548():331-343. PubMed ID: 28013516
[TBL] [Abstract][Full Text] [Related]
15. Clinical Applications of Antimicrobial Peptides (AMPs): Where do we Stand Now?
Divyashree M; Mani MK; Reddy D; Kumavath R; Ghosh P; Azevedo V; Barh D
Protein Pept Lett; 2020; 27(2):120-134. PubMed ID: 31553285
[TBL] [Abstract][Full Text] [Related]
16. Correlation between the secondary structure and surface activity of β-sheet forming cationic amphiphilic peptides and their anticancer activity.
Hadianamrei R; Tomeh MA; Brown S; Wang J; Zhao X
Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 2):112165. PubMed ID: 34715505
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic human neutrophil peptide-1 anti-tumor activity revealed by cellular biomechanics.
Gaspar D; Freire JM; Pacheco TR; Barata JT; Castanho MA
Biochim Biophys Acta; 2015 Feb; 1853(2):308-16. PubMed ID: 25447543
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial peptides, nanotechnology, and natural metabolites as novel approaches for cancer treatment.
Leite ML; da Cunha NB; Costa FF
Pharmacol Ther; 2018 Mar; 183():160-176. PubMed ID: 29024740
[TBL] [Abstract][Full Text] [Related]
19. Peptide-based cancer therapy: opportunity and challenge.
Wu D; Gao Y; Qi Y; Chen L; Ma Y; Li Y
Cancer Lett; 2014 Aug; 351(1):13-22. PubMed ID: 24836189
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in design of antimicrobial peptides and polypeptides toward clinical translation.
Jiang Y; Chen Y; Song Z; Tan Z; Cheng J
Adv Drug Deliv Rev; 2021 Mar; 170():261-280. PubMed ID: 33400958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
